Targeting the androgen receptor in triple-negative breast cancer: current perspectives

por Mina, Alain, Yoder, Rachel, Sharma, Priyanka
Publicado 2017

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

por Stecklein, Shane R., Kimler, Bruce F., Yoder, Rachel, Schwensen, Kelsey, Staley, Joshua M., Khan, Qamar J., O’Dea, Anne P., Nye, Lauren E., Elia, Manana, Heldstab, Jaimie, Home, Trisha, Hyter, Stephen, Isakova, Kamilla, Pathak, Harsh B., Godwin, Andrew K., Sharma, Priyanka
Publicado 2023

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

por Yoder, Rachel, Kimler, Bruce F., Staley, Joshua M., Schwensen, Kelsey, Wang, Yen Y., Finke, Karissa, O’Dea, Anne, Nye, Lauren, Elia, Manana, Crane, Gregory, McKittrick, Richard, Pluenneke, Robert, Madhusudhana, Sheshadri, Beck, Larry, Shrestha, Anuj, Corum, Larry, Marsico, Mark, Stecklein, Shane R., Godwin, Andrew K., Khan, Qamar J., Sharma, Priyanka
Publicado 2022